DE60238555D1 - PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS - Google Patents

PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS

Info

Publication number
DE60238555D1
DE60238555D1 DE60238555T DE60238555T DE60238555D1 DE 60238555 D1 DE60238555 D1 DE 60238555D1 DE 60238555 T DE60238555 T DE 60238555T DE 60238555 T DE60238555 T DE 60238555T DE 60238555 D1 DE60238555 D1 DE 60238555D1
Authority
DE
Germany
Prior art keywords
antibodies
parathormone
associated methods
methods
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238555T
Other languages
German (de)
Inventor
James Scott Hutchison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Diagnostics Investments LLC
Original Assignee
Quest Diagnostics Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25409386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60238555(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quest Diagnostics Investments LLC filed Critical Quest Diagnostics Investments LLC
Application granted granted Critical
Publication of DE60238555D1 publication Critical patent/DE60238555D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides

Abstract

Methods of preparing antibodies that recognize and bind three-dimensional epitopes of antigens are disclosed. The methods are particularly useful for preparing antibodies that bind the bioactive, three-dimensional amino terminus of parathyroid hormone. The antibodies so produced are used in diagnostic and therapeutic applications.
DE60238555T 2001-07-03 2002-07-03 PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS Expired - Lifetime DE60238555D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/898,398 US20030082179A1 (en) 2001-07-03 2001-07-03 Parathyroid hormone antibodies and related methods
PCT/US2002/021356 WO2003003986A2 (en) 2001-07-03 2002-07-03 Parathyroid hormone antibodies and related methods

Publications (1)

Publication Number Publication Date
DE60238555D1 true DE60238555D1 (en) 2011-01-20

Family

ID=25409386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238555T Expired - Lifetime DE60238555D1 (en) 2001-07-03 2002-07-03 PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS

Country Status (7)

Country Link
US (4) US20030082179A1 (en)
EP (1) EP1455821B1 (en)
JP (1) JP2004536831A (en)
AT (1) ATE490785T1 (en)
AU (1) AU2002354806A1 (en)
DE (1) DE60238555D1 (en)
WO (1) WO2003003986A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
BR0318454A (en) * 2003-08-08 2006-09-12 Abgenix Inc parathyroid hormone (pth) targeting antibodies and their uses
GB0329146D0 (en) * 2003-12-16 2004-01-21 Glaxosmithkline Biolog Sa Vaccine
US7959920B2 (en) * 2005-09-06 2011-06-14 Scantibodies Laboratory, Inc. Methods of making and using antibodies directed to parathyroid hormone
EP2133695A1 (en) * 2008-06-12 2009-12-16 Koninklijke Philips Electronics N.V. Parathyroid hormone assay
BR112012005331A2 (en) † 2009-09-14 2019-09-24 Koninl Philips Electronics Nv "Immunoassay for detecting an analyte in a sample, method for detecting analytes in a sample, biosensor device, and appropriate part kit for detecting an analyte in a sample"
CA2811140C (en) * 2010-08-31 2018-05-29 Kyowa Medex Co., Ltd. Method for measuring fibroblast growth factor-23 and reagent therefor
EP2631247A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
EP2775306B1 (en) 2013-03-08 2018-06-27 Immundiagnostik AG Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
KR101949405B1 (en) * 2016-10-21 2019-02-18 이화여자대학교 산학협력단 Animal model having hypoparathyroidism and method for producing the same
CN107255726B (en) * 2017-08-02 2018-09-14 江苏省原子医学研究所 Quantitatively detect the fluorescence immune chromatography test paper and preparation method thereof of human parathyroid hormone
US20200371118A1 (en) 2018-01-17 2020-11-26 Immundiagnostik Ag Biomarker predicting coronary artery diseases
IL284533B2 (en) * 2019-01-11 2024-02-01 Radius Health Inc Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog
CN113588602A (en) * 2021-07-08 2021-11-02 苏州诺为尔医疗科技有限责任公司 Rapid parathyroid hormone detection method

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33188A (en) * 1861-09-03 Improvement in mounting glaziers diamonds
US3880934A (en) 1972-02-10 1975-04-29 Syntex Inc Nitrophenyloxy-butanediols
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US4066410A (en) * 1975-09-15 1978-01-03 Nuclear-Medical Laboratories, Inc. Thyroid hormone assay
US4380580A (en) * 1978-04-10 1983-04-19 Miles Laboratories, Inc. Heterogenous chemiluminescent specific binding assay
US4369138A (en) * 1980-07-15 1983-01-18 Immuno Nuclear Corporation Parathyroid radioimmunoassay
SE453510B (en) * 1980-12-29 1988-02-08 Toyo Jozo Kk PEPTIME FOR ANALYSIS OF HUMANT PARATYROID HORMON
US4508828A (en) * 1983-03-21 1985-04-02 Immuno Nuclear Corporation Bioassay of parathyroid hormone
EP0273928B1 (en) * 1986-07-18 1997-01-08 The University Of Melbourne A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP
US5744444A (en) * 1989-10-27 1998-04-28 Haemopep Pharma Gmbh HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
US5395938A (en) * 1992-08-21 1995-03-07 Nichols Institute Diagnostics Biotinylated chemiluminescent labels and their conjugates, assays and assay kits
US5962637A (en) * 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
DE4434551A1 (en) 1994-09-28 1996-04-04 Forssmann Wolf Georg Prof Dr D Peptides from the sequence of hPTH (1-37)
JP2729159B2 (en) * 1994-10-31 1998-03-18 日清製粉株式会社 Monoclonal antibody of human glicentin, hybridoma producing the antibody, and method for quantifying human glicentin using the same
GB9507985D0 (en) * 1995-04-19 1995-06-07 Orion Yhtymae Oy Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it
DE19725365B4 (en) * 1997-06-16 2006-05-24 C. Rob. Hammerstein Gmbh & Co. Kg Vehicle seat with forwardly displaceable backrest and forwardly displaceable seat support
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
DE19961350A1 (en) * 1999-12-17 2001-06-21 Immundiagnostik Ag Method for determining parathyroid activity in a human sample
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84

Also Published As

Publication number Publication date
WO2003003986A2 (en) 2003-01-16
WO2003003986A3 (en) 2004-07-01
EP1455821A2 (en) 2004-09-15
US20030082179A1 (en) 2003-05-01
ATE490785T1 (en) 2010-12-15
US20060024772A1 (en) 2006-02-02
JP2004536831A (en) 2004-12-09
EP1455821B1 (en) 2010-12-08
AU2002354806A1 (en) 2003-01-21
US20050003493A1 (en) 2005-01-06
EP1455821A4 (en) 2006-04-12
US20060286107A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
DE60238555D1 (en) PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
TW200510459A (en) RG1 antibodies and uses thereof
HK1109636A1 (en) Human antibodies and proteins
HUP9802212A2 (en) Recombinant anti-cd4 antibodies for human therapy
DE60329489D1 (en) FUSION PROTEINS HUMANIZED G250-SPECIFIC ANTIBODY AND USES THEREOF
GEP20074091B (en) Cripto blocking antibodies and uses thereof
IL195338A (en) Antibody comprising an fc variant comprising d or e amino acid substitution at position 239 and pharmaceutical composition and use thereof
DK1572748T3 (en) Humanized antibody (H14.18) of mouse 14.18 antibody that binds to GD2 and its fusion protein with IL-2
EP1383785A4 (en) Recombinant tumor specific antibody and use thereof
CY1110033T1 (en) ARTIFICIAL HUMAN THERAPEUTIC ANTIBODIES AGAINST ISMORPHES CD45
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
DE602006013428D1 (en) CHIMAIR RECOMBINANT ANTIGENS OF TOXOPLASMA GONDII
DE60018761D1 (en) THERAPEUTIC ANTIBODIES TO THE MUC-1 ANTIGEN AND METHOD FOR THEIR USE
DK1362109T3 (en) Recombinant oligomeric protein complexes with enhanced immunogenic potential
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
WO2003104425A3 (en) Novel stable anti-cd22 antibodies
DE69626423D1 (en) METHOD AND COMPOSITION FOR REFORMING MULTI-EPITOPIC ANTIGENS TO INTRODUCE THE IMMUNE RESPONSE
HUP0302681A2 (en) Javelinization of protein antigens to heat shock proteins
GB0008305D0 (en) Treatment of fungal infections
WO2005007673A3 (en) Immunogenic peptides
DE60315827D1 (en) IMPROVED POLYSACCHARIDE AND GLYCOCONJUGATE VACCINE
EP0972054A4 (en) Enhancement of immune response using targeting molecules
CY1106200T1 (en) ANTIBODIES TO CASPASE-8, THEIR PREPARATION AND USE
WO2003106478A3 (en) ANTIBODIES THAT BIND alphaE INTEGRIN